Literature DB >> 26359979

Nutrient Competition: A New Axis of Tumor Immunosuppression.

Madhusudhanan Sukumar1, Rahul Roychoudhuri1, Nicholas P Restifo2.   

Abstract

It is thought that cancer cells engage in Warburg metabolism to meet intrinsic biosynthetic requirements of cell growth and proliferation. Papers by Chang et al. and Ho et al. show that Warburg metabolism enables tumor cells to restrict glucose availability to T cells, suppressing anti-tumor immunity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26359979      PMCID： PMC6327313          DOI： 10.1016/j.cell.2015.08.064

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  10 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

Authors:  Madhusudhanan Sukumar; Jie Liu; Yun Ji; Murugan Subramanian; Joseph G Crompton; Zhiya Yu; Rahul Roychoudhuri; Douglas C Palmer; Pawel Muranski; Edward D Karoly; Robert P Mohney; Christopher A Klebanoff; Ashish Lal; Toren Finkel; Nicholas P Restifo; Luca Gattinoni
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 3.  Metabolic regulation of T lymphocytes.

Authors:  Nancie J MacIver; Ryan D Michalek; Jeffrey C Rathmell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Posttranscriptional control of T cell effector function by aerobic glycolysis.

Authors:  Chih-Hao Chang; Jonathan D Curtis; Leonard B Maggi; Brandon Faubert; Alejandro V Villarino; David O'Sullivan; Stanley Ching-Cheng Huang; Gerritje J W van der Windt; Julianna Blagih; Jing Qiu; Jason D Weber; Edward J Pearce; Russell G Jones; Erika L Pearce
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

5.  Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean Jacques Grob; C Lance Cowey; Christopher D Lao; Dirk Schadendorf; Reinhard Dummer; Michael Smylie; Piotr Rutkowski; Pier F Ferrucci; Andrew Hill; John Wagstaff; Matteo S Carlino; John B Haanen; Michele Maio; Ivan Marquez-Rodas; Grant A McArthur; Paolo A Ascierto; Georgina V Long; Margaret K Callahan; Michael A Postow; Kenneth Grossmann; Mario Sznol; Brigitte Dreno; Lars Bastholt; Arvin Yang; Linda M Rollin; Christine Horak; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2015-05-31       Impact factor: 91.245

6.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

7.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 8.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 9.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

10.  Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

Authors:  Ping-Chih Ho; Jessica Dauz Bihuniak; Andrew N Macintyre; Matthew Staron; Xiaojing Liu; Robert Amezquita; Yao-Chen Tsui; Guoliang Cui; Goran Micevic; Jose C Perales; Steven H Kleinstein; E Dale Abel; Karl L Insogna; Stefan Feske; Jason W Locasale; Marcus W Bosenberg; Jeffrey C Rathmell; Susan M Kaech
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582
  10 in total
  45 in total

1.  Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review.

Authors:  Philippe Icard; Luc Ollivier; Patricia Forgez; Joelle Otz; Marco Alifano; Ludovic Fournel; Mauro Loi; Juliette Thariat
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

2.  Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.

Authors:  Shilpak Chatterjee; Paramita Chakraborty; Anusara Daenthanasanmak; Supinya Iamsawat; Gabriela Andrejeva; Libia A Luevano; Melissa Wolf; Uday Baliga; Carsten Krieg; Craig C Beeson; Meenal Mehrotra; Elizabeth G Hill; Jeffery C Rathmell; Xue-Zhong Yu; Andrew S Kraft; Shikhar Mehrotra
Journal:  Clin Cancer Res       Date:  2018-10-16       Impact factor: 12.531

3.  Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition.

Authors:  Jiang Li; Yingying Ye; Zhihan Liu; Guoyang Zhang; Huiqi Dai; Jiaqian Li; Boxuan Zhou; Yihong Li; Qiyi Zhao; Jingying Huang; Jingwei Feng; Shu Liu; Peigang Ruan; Jinjing Wang; Jiang Liu; Min Huang; Xinwei Liu; Shubin Yu; Ziyang Liang; Liping Ma; Xiaoxia Gou; Guoliang Zhang; Nian Chen; Yiwen Lu; Can Di; Qidong Xia; Jiayao Pan; Ru Feng; Qingqing Cai; Shicheng Su
Journal:  Nat Cancer       Date:  2022-04-28

4.  Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.

Authors:  Arthur J Liu; Shivanand Pudakalakatti; Ashvin R Jaiswal; Prasanta Dutta; Priyamvada Jayaprakash; Todd Bartkowiak; Casey R Ager; Zhi-Qiang Wang; Alexandre Reuben; Zachary A Cooper; Cristina Ivan; Zhenlin Ju; Felix Nwajei; Jing Wang; Michael A Davies; R Eric Davis; Jennifer A Wargo; Pratip K Bhattacharya; David S Hong; Michael A Curran
Journal:  Cancer Immunol Res       Date:  2020-09-11       Impact factor: 11.151

5.  Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion.

Authors:  Brian Koss; Bradley D Shields; Erin M Taylor; Aaron J Storey; Stephanie D Byrum; Allen J Gies; Charity L Washam; Samrat Roy Choudhury; Jeong Hyun Ahn; Hidetaka Uryu; Jason B Williams; Kimberly J Krager; Tung-Chin Chiang; Samuel G Mackintosh; Rick D Edmondson; Nukhet Aykin-Burns; Thomas F Gajewski; Gang Greg Wang; Alan J Tackett
Journal:  Cancer Res       Date:  2020-10-01       Impact factor: 12.701

6.  TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy.

Authors:  Lingyun Li; Xia Liu; Katherine L Sanders; James L Edwards; Jian Ye; Fusheng Si; Aiqin Gao; Lan Huang; Eddy C Hsueh; David A Ford; Daniel F Hoft; Guangyong Peng
Journal:  Cell Metab       Date:  2018-10-18       Impact factor: 27.287

Review 7.  Metabolic Strategies for Inhibiting Cancer Development.

Authors:  Philippe Icard; Mauro Loi; Zherui Wu; Antonin Ginguay; Hubert Lincet; Edouard Robin; Antoine Coquerel; Diana Berzan; Ludovic Fournel; Marco Alifano
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

Review 8.  The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy.

Authors:  Bonnie L Russell; Selisha A Sooklal; Sibusiso T Malindisa; Lembelani Jonathan Daka; Monde Ntwasa
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

Review 9.  Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications.

Authors:  Alice Indini; Francesco Grossi; Mario Mandalà; Daniela Taverna; Valentina Audrito
Journal:  Biomedicines       Date:  2021-05-26

Review 10.  Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.

Authors:  Xia Liu; Daniel F Hoft; Guangyong Peng
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.